Rucaparib Camsylate inhibits DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1), thus it belongs to a class known as PARP inhibitors, which have proven to have anti-cancer activity in a number of cancers.
Rucaparib Camsylate is a camphorsulfonate salt obtained by reacting rucaparib with one molar equivalent of (1S, 4R-)-camphorsufonic acid. It hasa role as an EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor.